Eliano Navarese,

Watch time: 5m 42s (1 video)

Lars Søndergaard, Darren Mylotte, Andreas Rück, et al

Watch time: 2h 17m (7 videos)

Pascal Vranckx,

Watch time: 04:42 (1 video)

Jonathan Hill, James Spratt, Charalambos Antoniades, et al

Watch time: 11h 6m (20 videos)


Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).


Optimum Utilisation of Novel Antiplatelet Agents in Clinical Practice


Interventional Cardiology Review 2014;9(3):164–7

Bioresorbable Scaffolds


Interventional Cardiology Review 2014;9(3):175–9

Evidence for Benefit of Percutaneous Coronary Intervention for Chronically Occluded Coronary Arteries (CTO) – Clinical and Health Economic Outcomes


Interventional Cardiology Review 2014;9(3):190–4

New Advances in Chronic Total Occlusions


Interventional Cardiology Review 2014;9(3):208–12